Abe Ayumi, Takano Kenichi, Seki Nobuhiko, Jitsukawa Sumito, Yamamoto Motohisa, Takahashi Hiroki, Himi Tetsuo
Department of Otolaryngology, Sapporo Medical University School of Medicine , Sapporo , Japan.
Mod Rheumatol. 2014 Nov;24(6):949-52. doi: 10.3109/14397595.2014.891964. Epub 2014 Mar 26.
Mikulicz's disease (MD) is an immunoglobulin (Ig) G4-related disease with systemic symptoms. Submandibular gland (SMG) biopsy is recommended for patients with possible IgG4-related MD for accurate differential diagnosis; however, it is difficult for certain patients to undergo this procedure. In contrast, labial salivary gland (LSG) biopsy is more convenient. Here we present an analysis of patients with IgG4-related MD whose LSG specimens were infiltrated with abundant IgG4-positive plasma cells.
Sixteen patients diagnosed with IgG4-related MD underwent simultaneous SMG and LSG biopsies. We evaluated patients' serological and (18)F-fluoro-2-deoxyglucose-positron emission tomography/computed tomography ((18)F-FDG-PET/CT) and grouped them as LSG+ (LSG specimens with > 40% IgG4-positive plasma cells/IgG-positive plasma cells, 11 patients) or LSG- (LSG specimens with < 40% IgG4-positive plasma cells/IgG-positive plasma cells, 6 patients).
There were not significant differences in serum IgG and IgG4 levels between the two groups; however, serum concentrations of soluble interleuikin-2 receptor (sIL-2R) were significantly higher in the LSG+ group. All patients with increased (18)F-FDG uptake in their parotid glands were a part of the LSG+ group.
When a SMG biopsy is not possible, the serum concentration of sIL-2R and (18)F-FDG-PET/CT findings may predict whether LSG biopsy will facilitate the diagnosis of IgG4-related MD.
米库利奇病(MD)是一种伴有全身症状的免疫球蛋白(Ig)G4相关疾病。对于可能患有IgG4相关MD的患者,建议进行下颌下腺(SMG)活检以进行准确的鉴别诊断;然而,某些患者难以接受该检查。相比之下,唇唾液腺(LSG)活检则更为便捷。在此,我们对LSG标本中有大量IgG4阳性浆细胞浸润的IgG4相关MD患者进行了分析。
16例被诊断为IgG4相关MD的患者同时接受了SMG和LSG活检。我们评估了患者的血清学及氟-2-脱氧葡萄糖正电子发射断层扫描/计算机断层扫描((18)F-FDG-PET/CT)结果,并将他们分为LSG+组(LSG标本中IgG4阳性浆细胞/IgG阳性浆细胞>40%,共11例患者)或LSG-组(LSG标本中IgG4阳性浆细胞/IgG阳性浆细胞<40%,共6例患者)。
两组患者的血清Ig和IgG4水平无显著差异;然而,LSG+组的可溶性白细胞介素-2受体(sIL-2R)血清浓度显著更高。所有腮腺(18)F-FDG摄取增加的患者均属于LSG+组。
当无法进行SMG活检时,sIL-2R的血清浓度及(18)F-FDG-PET/CT结果可能有助于预测LSG活检是否有利于IgG4相关MD的诊断。